Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized comparative study of intravenous Bondronat in painful bone metastases from breast cancer
2005-004760-23Phase 2Active
- Sponsor
- Roche Farma, S.A.
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ibandronic acid in breast cancer and bone metastases (2 arms), sponsored by Roche Farma, S.A. Primary endpoints: Pain response and Pain response by visual analog scale. Started Jan 2006; status: active.
02
Drugs
ibandronic acid
03
Conditions
breast cancerbone metastases
Beyond the preview
Go deeper on 2005-004760-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004760-23.